Zborník príspevkov z vedeckej konferencie - Department of ...
Zborník príspevkov z vedeckej konferencie - Department of ... Zborník príspevkov z vedeckej konferencie - Department of ...
1 st fraction 1.5 1.0 0.5 (x10,000,000) 1:TIC (1.00) 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 2 nd fraction 1.75 (x10,000,000) 1:TIC (1.00) 1.50 1.25 1.00 0.75 0.50 0.25 0.5 0.0 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 Inten.(x10,000) 2.0 279.137 251.120 384.201 582.309 1.5 1.0 185.128 450.223 560.290 727.725 897.807 761.004 833.402 3 th fraction 1.75 (x10,000,000) 1:TIC (1.00) 1.50 1.25 1.00 0.75 0.50 0.25 4.0 3.0 Inten.(x10,000) 406.187 2.0 185.102 1.0 102.532 255.935 309.918 487.841 604.286 713.832 933.745 806.587 848.519 1006.112 1106.443 1301.230 0.0 250 500 750 1000 1250 m/z Inten.(x10,000) 234.987 2.0 185.102 1.5 1.0 0.5 0.0 Inten.(x1,000) 1.0 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0.0 14200 14225 14250 14275 14300 14325 14350 14375 mass 1026.294 1101.279 1194.023 1305.816 1186.502 250 500 750 1000 1250 m/z 301.121 421.924 450.223 560.267 601.609 14303.505 782.171 822.574 250 500 750 1000 1250 m/z 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 Fig.5: TIC traces (a), MS spectra (b) and deconvoluted MS spectrum (c) from HPLC/MS analysis of the fractions obtained during the preparative ITP isolation of lysozyme standard. For details, see Experimental. Zborník príspevkov z 18. medzinárodnej vedeckej konferencie "Analytické metódy a zdravie loveka", ISBN 978-80-969435-7-9 - 129 - c) b) b) b) a) a) a) hotel Falkensteiner, Bratislava 11. - 14. 10. 2010
1 st fraction 1.50 1.25 1.00 0.75 0.50 0.25 (x10,000,000) 1:TIC (1.00) Inten.(x10,000) 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 2 nd fraction (x10,000,000) 1.75 1:TIC (1.00) 1.50 1.25 1.00 0.75 0.50 0.25 1.5 1.0 0.5 0.0 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 2.0 Inten.(x10,000) 3 th fraction 1.50 1.25 1.00 0.75 0.50 2.5 2.0 1.5 1.0 0.5 0.0 229.139 773.738 727.879 857.544 907.489 1029.333 1079.652 1125.790 594.956 125.975 279.153 466.558 1276.662 175.068 395.221 (x10,000,000) 1:TIC (1.00) Inten.(x10,000) 2.0 1.5 1.0 0.5 0.0 301.154 167.011 472.267 913.409 219.951 125.986 661.229 509.236 1087.108 757.635 823.989 250 500 750 1000 1250 m/z 1.0 Inten.(x1,000) 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 14756.662 0.0 14500 14550 14600 14650 14700 14750 14800 14850 14900 14950 mass 1472.921 250 500 750 1000 1250 m/z 123.035 185.089 251.105 301.138 509.257 428.707 431.833 582.286 693.592 250 500 750 1000 1250 m/z 0.25 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 Fig.6: TIC traces (a), MS spectra (b) and deconvoluted MS spectrum (c) from HPLC/MS analysis of the fractions obtained during the preparative ITP isolation of saliva sample. For details, see Experimental. Zborník príspevkov z 18. medzinárodnej vedeckej konferencie "Analytické metódy a zdravie loveka", ISBN 978-80-969435-7-9 858.710 970.388 946.649 - 130 - c) b) b) a) a) b) a) hotel Falkensteiner, Bratislava 11. - 14. 10. 2010
- Page 86 and 87: Tabuka 2. Zloženie mastných kysel
- Page 88 and 89: Tabuka 3. Obsah jednotlivých izom
- Page 90 and 91: [19] J. Blaško, R. Kubinec, I. Ost
- Page 92 and 93: 2. Experimental Instrumentation Flo
- Page 94 and 95: Analysis of real samples The boiler
- Page 96 and 97: a) b) 2 2 1 1 3 3 3 3 Fig. 1 The ex
- Page 98 and 99: Conclusion remarks The identificati
- Page 100 and 101: screening, possible interactions am
- Page 102 and 103: The design consists of a factorial
- Page 104 and 105: elative area 15 10 5 -1,68 -1,00 0,
- Page 106 and 107: It can be seen that the programms d
- Page 108 and 109: nevodíkovými atómami izotropne s
- Page 110 and 111: O22—C6—C7 109.57 (15) C10—C11
- Page 112 and 113: [8] S. Teklu, L.L. Gundersen, T. La
- Page 114 and 115: iónom kovu môže by ovplyvnená a
- Page 116 and 117: V alšej asti práce sme študovali
- Page 118 and 119: vzorky, pomer hmotností vzorky a s
- Page 120 and 121: literatúre nenašli informácie. M
- Page 122 and 123: Záver Pri úprave vzorky pôdy met
- Page 124 and 125: galactose-4-epimerase [6, 7]. First
- Page 126 and 127: Abundance Abundance Abundance 1x10
- Page 128 and 129: Galactitol [mmol/mol creatinine] 60
- Page 130 and 131: References [1] J.T.R. Clarke, Clini
- Page 132 and 133: structural information of the analy
- Page 134 and 135: (x10,000,000) 1.5 1:TIC (1.00) 1.4
- Page 138 and 139: 1 st fraction 1.5 1.0 0.5 (x10,000,
- Page 140 and 141: RAPID LIQUID CHROMATOGRAPHY-MASS SP
- Page 142 and 143: the LC-ESI-IT-TOF MS analyzer. HPLC
- Page 144 and 145: (x10,000,000) 1:TIC (1.00) 4:TIC (1
- Page 146 and 147: Figure 5 is showing MS and MS/MS sp
- Page 148 and 149: Figure 7 present MS and MS/MS spect
- Page 150 and 151: MS and MS/MS spectra of potential m
- Page 152 and 153: DVOUROZMĚRNÁ KAPALINOVÁ CHROMATO
- Page 154 and 155: řřů ěř Pnčč ěě : ččěP2D
- Page 156 and 157: řěůčťě čě č ěě Obr. 6.
- Page 158 and 159: Obr. 9. Separaci metabolitů indolo
- Page 160 and 161: STANOVENIE OXIDANÝCH PRODUKTOV OXI
- Page 162 and 163: e d c b a G NO - 3 NO - 2 NO - 2 NO
- Page 164 and 165: Na obr. 4b je elektroforeogram z IT
- Page 166 and 167: Vhodnos navrhnutého analytického
- Page 168 and 169: Experimentálna as CZE separácie b
- Page 170 and 171: Séria kalibraných meraní modelov
- Page 172 and 173: Výsledky a diskusia Na obr. 2 sú
- Page 174 and 175: Tab. 2: Parametre regresných rovn
- Page 176 and 177: Tab. 3: Opakovatenosti migraných a
- Page 178 and 179: chloridu, typickej makrozložky v C
- Page 180 and 181: kationického roztoku elektrolytu b
- Page 182 and 183: Tab. 2: Stanovenie aniónov a kati
- Page 184 and 185: CHARAKTERIZÁCIA RP-HPLC FRAKCIONOV
1 st fraction<br />
1.5<br />
1.0<br />
0.5<br />
(x10,000,000)<br />
1:TIC (1.00)<br />
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0<br />
2 nd fraction<br />
1.75 (x10,000,000)<br />
1:TIC (1.00)<br />
1.50<br />
1.25<br />
1.00<br />
0.75<br />
0.50<br />
0.25<br />
0.5<br />
0.0<br />
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0<br />
Inten.(x10,000)<br />
2.0<br />
279.137<br />
251.120<br />
384.201<br />
582.309<br />
1.5<br />
1.0<br />
185.128<br />
450.223 560.290<br />
727.725<br />
897.807<br />
761.004<br />
833.402<br />
3 th fraction<br />
1.75 (x10,000,000)<br />
1:TIC (1.00)<br />
1.50<br />
1.25<br />
1.00<br />
0.75<br />
0.50<br />
0.25<br />
4.0<br />
3.0<br />
Inten.(x10,000)<br />
406.187<br />
2.0 185.102<br />
1.0<br />
102.532<br />
255.935<br />
309.918<br />
487.841<br />
604.286 713.832 933.745<br />
806.587<br />
848.519 1006.112 1106.443<br />
1301.230<br />
0.0<br />
250 500 750 1000 1250 m/z<br />
Inten.(x10,000)<br />
234.987<br />
2.0<br />
185.102<br />
1.5<br />
1.0<br />
0.5<br />
0.0<br />
Inten.(x1,000)<br />
1.0<br />
0.9<br />
0.8<br />
0.7<br />
0.6<br />
0.5<br />
0.4<br />
0.3<br />
0.2<br />
0.1<br />
0.0<br />
14200 14225 14250 14275 14300 14325 14350 14375 mass<br />
1026.294<br />
1101.279<br />
1194.023<br />
1305.816<br />
1186.502<br />
250 500 750 1000 1250 m/z<br />
301.121<br />
421.924<br />
450.223<br />
560.267<br />
601.609<br />
14303.505<br />
782.171<br />
822.574<br />
250 500 750 1000 1250 m/z<br />
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0<br />
Fig.5: TIC traces (a), MS spectra (b) and deconvoluted MS spectrum (c) from HPLC/MS analysis <strong>of</strong> the fractions obtained<br />
during the preparative ITP isolation <strong>of</strong> lysozyme standard. For details, see Experimental.<br />
<strong>Zborník</strong> <strong>príspevkov</strong><br />
z 18. medzinárodnej <strong>vedeckej</strong> <strong>konferencie</strong><br />
"Analytické metódy a zdravie loveka", ISBN 978-80-969435-7-9<br />
- 129 -<br />
c)<br />
b)<br />
b)<br />
b)<br />
a)<br />
a)<br />
a)<br />
hotel Falkensteiner, Bratislava<br />
11. - 14. 10. 2010
Change language